Gene · 10987
Papers2,142
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,142
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IGF2BP2 acts as a m6A modification regulator in laryngeal squamous cell carcinoma through facilitating CDK6 mRNA stabilization. | Cell Death Discov | 2023 | 37816718 | PubTator, text mining | PubMed |
| Genomic architecture of autism spectrum disorder in Qatar: The BARAKA-Qatar Study. | Genome Med | 2023 | 37805537 | PubTator, text mining | PubMed |
| The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer. | Front Endocrinol (Lausanne) | 2023 | 37795365 | PubTator, text mining | PubMed |
| The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control. | Br J Cancer | 2023 | 37794178 | PubTator, text mining | PubMed |
| Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration. | Front Pharmacol | 2023 | 37790807 | PubTator, text mining | PubMed |
| Role of non-canonical post-translational modifications in gastrointestinal tumors. | Cancer Cell Int | 2023 | 37777749 | PubTator, text mining | PubMed |
| UBL3 Interaction with α-Synuclein Is Downregulated by Silencing MGST3. | Biomedicines | 2023 | 37760932 | PubTator, text mining | PubMed |
| UBE2V2 promotes metastasis by regulating EMT and predicts a poor prognosis in lung adenocarcinoma. | Cancer Med | 2023 | 37755128 | PubTator, text mining | PubMed |
| Spotlights on ubiquitin-specific protease 12 (USP12) in diseases: from multifaceted roles to pathophysiological mechanisms. | J Transl Med | 2023 | 37752518 | PubTator, text mining | PubMed |
| Erratum: Down-Regulation of the Cyclin-Dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis. | Hepatology | 2023 | 37748046 | PubTator, text mining | PubMed |
| A Novel Scoring Model of Deubiquitination Patterns Predicts Prognosis and Immunotherapeutic Response in Hepatocellular Carcinoma. | Transl Oncol | 2023 | 37734237 | PubTator, text mining | PubMed |
| Construction of an Ultra-Large Phage Display Library by Kunkel Mutagenesis and Rolling Circle Amplification. | Methods Mol Biol | 2023 | 37679621 | PubTator, text mining | PubMed |
| The emerging roles of SUMOylation in pulmonary diseases. | Mol Med | 2023 | 37670258 | PubTator, text mining | PubMed |
| Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application. | J Exp Clin Cancer Res | 2023 | 37658402 | PubTator, text mining | PubMed |
| The expression of nicotinic acetylcholine receptor subunits and their associations with local immune cells and prognosis in oral squamous cell carcinoma. | Cancer Med | 2023 | 37654227 | PubTator, text mining | PubMed |
| The Great Game between Plants and Viruses: A Focus on Protein Homeostasis. | Int J Mol Sci | 2023 | 37628763 | PubTator, text mining | PubMed |
| Ubiquitin Engineering for Interrogating the Ubiquitin-Proteasome System and Novel Therapeutic Strategies. | Cells | 2023 | 37626927 | PubTator, text mining | PubMed |
| Fungal COP9 signalosome assembly requires connection of two trimeric intermediates for integration of intrinsic deneddylase. | Proc Natl Acad Sci U S A | 2023 | 37603767 | PubTator, text mining | PubMed |
| The COP9 signalosome reduces neuroinflammation and attenuates ischemic neuronal stress in organotypic brain slice culture model. | Cell Mol Life Sci | 2023 | 37597109 | PubTator, text mining | PubMed |
| Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence. | J Exp Clin Cancer Res | 2023 | 37596619 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10987/papers?page=8